Search

The Belinda Parker laboratory explores interactions in the cancer microenvironment that prevent or support tumour invasion and spread (metastasis) to other tissues, including bone. Our overall objective is to uncover new... Read more

Acquired treatment resistance, whereby patients respond well to primary treatment but eventually develop drug resistance, is common across a range of cancer types. It is particularly problematic in the most common form of ovarian... Read more

Many breast and ovarian cancer run in families (termed hereditary cancers), but only about a third of these familial cancers are caused by genes we know about such as BRCA1 and BRCA2. Women with a family history of hereditary... Read more

The Kara Britt lab's overall objective is to uncover new cell specific biomarkers that associate with breast cancer risk that also direct the development of novel prevention strategies. We also have numerous breast cancer... Read more

Ovarian cancer is one of the deadliest cancers in women, and a greater understanding of the molecular events is urgently needed to identify new targets for treatment. The Kylie Gorringe Lab addresses this goal by using... Read more

One-in-seven men will be diagnosed with prostate cancer (PC) in their lifetime and PC related deaths are >3000 per year in Australia. Despite approaches such as surgical removal of the prostate, radiation therapy and androgen... Read more